The implantable cardioverter defibrillator (ICD) represented a breakthrough in the prevention of sudden cardiac death. In addition to its use in secondary prevention, the indication of ICD therapy in primary prevention is also being intensively researched. A study published last year evaluated the relevance of ICD implantation in the acute phase of acute myocarditis and a registry study investigated the benefits of a wearable cardioverter defibrillator (WCD) for the prevention of sudden cardiac death in post-infarction patients.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Asthma in adults
When do pneumology specialists come into play?
- Cutaneous lupus erythematosus
From diagnostic workup to successful treatment
- Guideline update
Dietary recommendations for Crohn’s disease and colitis
- Circadian rhythm during Ramadan
Disturbed sleep patterns lead to metabolic stress
- Case Report
Breast cancer metastases in the bladder
- Findings from the ALS Symposium 2024 in Montreal
Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)
- Efficacy, mechanism of action and clinical effects
Garlic and high blood pressure
- Moderate to severe chronic hand eczema